Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        Romidepsin by Bristol-Myers Squibb for Thyroid Cancer: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Thyroid Cancer. According to GlobalData, Phase...
                                                Data Insights
                                                
                                        Romidepsin by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor. According to GlobalData, Phase...